Diabetes Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Diabetes stocks.

Diabetes Stocks Recent News

Date Stock Title
May 10 HUMA Humacyte Inc (HUMA) Q1 2024 Earnings: Aligns with Analyst Projections Amid Strategic Advances
May 10 HUMA Peering Into Humacyte's Recent Short Interest
May 10 HALO Biotech Stocks To Watch: Halozyme Actionable Now After Earnings-Fueled Breakout
May 10 HUMA Humacyte GAAP EPS of -$0.29 misses by $0.06
May 10 MRK Merck's (NYSE:MRK) investors will be pleased with their notable 90% return over the last three years
May 10 HUMA Humacyte First Quarter 2024 Financial Results and Business Update
May 10 RZLT Rezolute, Inc. (NASDAQ:RZLT) has caught the attention of institutional investors who hold a sizeable 47% stake
May 10 MRK Merck: The Worst Has Been Avoided (Rating Upgrade)
May 9 VTVT vTv Therapeutics GAAP EPS of -$1.17, revenue of $1M
May 9 VTVT vTv Therapeutics Announces 2024 First Quarter Financial Results and Provides Corporate Update
May 9 HUMA Humacyte Q1 2024 Earnings Preview
May 9 MRK Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know
May 9 MRK Merck says Keytruda failed as first-line therapy for uterine cancer
May 9 MRK Health Canada Approves KEYTRUDA® for adult patients with locally advanced unresectable or metastatic biliary tract carcinoma, in combination with gemcitabine-based chemotherapy
May 9 MRK Merck Provides Update on Phase 3 KEYNOTE-B21 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus Chemotherapy, With or Without Radiotherapy, for Patients With Newly Diagnosed, High-Risk Endometrial Cancer After Surgery With Curative Intent
May 9 PETQ Q1 2024 PetIQ Inc Earnings Call
May 9 PETQ PetIQ Inc (PETQ) (Q1 2024) Earnings Call Transcript Highlights: Strong Growth and Margin ...
May 8 PETQ PetIQ Non-GAAP EPS of $0.58 beats by $0.15, revenue of $308.4M beats by $7.96M
May 8 PETQ PetIQ, Inc. Reports First Quarter 2024 Financial Results
May 8 HALO Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q1 2024 Earnings Call Transcript
Diabetes

Diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic disorders in which there are high blood sugar levels over a prolonged period. Symptoms of high blood sugar include frequent urination, increased thirst, and increased hunger. If left untreated, diabetes can cause many complications. Acute complications can include diabetic ketoacidosis, hyperosmolar hyperglycemic state, or death. Serious long-term complications include cardiovascular disease, stroke, chronic kidney disease, foot ulcers, and damage to the eyes.Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body not responding properly to the insulin produced. There are three main types of diabetes mellitus:
Type 1 DM results from the pancreas' failure to produce enough insulin due to loss of beta cells. This form was previously referred to as "insulin-dependent diabetes mellitus" (IDDM) or "juvenile diabetes". The cause is unknown.
Type 2 DM begins with insulin resistance, a condition in which cells fail to respond to insulin properly. As the disease progresses, a lack of insulin may also develop. This form was previously referred to as "non insulin-dependent diabetes mellitus" (NIDDM) or "adult-onset diabetes". The most common cause is a combination of excessive body weight and insufficient exercise.
Gestational diabetes is the third main form, and occurs when pregnant women without a previous history of diabetes develop high blood sugar levels.Prevention and treatment involve maintaining a healthy diet, regular physical exercise, a normal body weight, and avoiding use of tobacco. Control of blood pressure and maintaining proper foot care are important for people with the disease. Type 1 DM must be managed with insulin injections. Type 2 DM may be treated with medications with or without insulin. Insulin and some oral medications can cause low blood sugar. Weight loss surgery in those with obesity is sometimes an effective measure in those with type 2 DM. Gestational diabetes usually resolves after the birth of the baby.As of 2015, an estimated 415 million people had diabetes worldwide, with type 2 DM making up about 90% of the cases. This represents 8.3% of the adult population, with equal rates in both women and men. As of 2014, trends suggested the rate would continue to rise. Diabetes at least doubles a person's risk of early death. From 2012 to 2015, approximately 1.5 to 5.0 million deaths each year resulted from diabetes. The global economic cost of diabetes in 2014 was estimated to be US$612 billion. In the United States, diabetes cost $245 billion in 2012.

Browse All Tags